UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...
Researchers from two labs in the Human Biology division at Fred Hutch Cancer Center recently published two studies aimed at better understanding how a notorious gene fusion — ZFTA-RELA — drives rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results